Articles
South Australian feature: Biotechnology in the field
The South Australian Research and Development Institute (SARDI) is part of South Australia's Department of Primary Industries and Resources. [ + ]
South Australian Interview: Dancing with the elephants
Dr Deborah Rathjen, CEO of listed Adelaide company Bionomics, says there are plenty of positive signs that South Australia has a burgeoning biotechnology industry. [ + ]
South Australian feature: The engine driver
Dr Jurgen Michaelis is the man in the hot seat at Bio Innovation SA, the State government's engine of choice for accelerating growth of a commercial bioscience sector. [ + ]
South Australian feature: How a 15-minute city bred a biohub
If Adelaide is the city of churches, there can be no doubt that its suburb Thebarton is the borough of biotechs. [ + ]
Tasmanian feature: Wired island
Tasmania's Intelligent Island program has a central focus on bioinformatics, with a proposal to build an R&D centre of excellence that will attract world class researchers to Tasmania, generate IP and spin off commercial companies. [ + ]
Tasmanian feature: GM ban impacts on local bio
A moratorium by the Tasmanian government on genetically modified organisms has the potential to seriously impact future biotechnology research in the state, especially in the agricultural sector. [ + ]
Tasmanian feature: All in the family
Prof Terry Dwyer is the Director of the Menzies Research Institute, which he established in 1988. The institute is an epidemiology focused research organisation looking at the causes of human diseases. [ + ]
Tasmanian feature: Tasmanian Tigers
Tasmania might be the smallest Australian state, but it has some advantages for the biotechnology industry that the other states can't even dream of. [ + ]
Victorian feature: Investment Issues
Finance and funding issues affecting the biotechnology industry appear to be something of a chicken and egg scenario. [ + ]
Victorian feature: Infrastructure key to biotech success
The need to build Victoria's biotechnology infrastructure base has been recognised through the establishment of the Biotechnology Platform Technology Working Party. [ + ]
Victorian feature: Vic bio warns against early IPO
Had Amrad Corporation been conceived in the United States it would only now be considering a public listing, according to its managing director. [ + ]
Victorian feature: Smaller players face big issues
While Victorian companies who have been around the block a few times reckon the latest batch of biotech newcomers have got it relatively easy, the feeling out there is quite different. [ + ]
Victorian feature: Biotech's a real synch
One word is consistently on people's lips when discussing Victoria's biotechnology scene: hub. [ + ]
Analysing venture capital
Venture capitalists need to be as a good at analysing their clients as any psychiatrist, says Dr Mike Hirshorn, a medical doctor turned venture capitalist, now with Sydney-based VC Nanyang Ventures. [ + ]
The Mitchell viewpoint
Dr Graham Mitchell is in a unique position to comment on biotechnology in Victoria. As one of the four scientists in biotech consultancy Foursight Associates, he is one of the chief scientific advisers to the Victorian government. [ + ]
